List of Imaging Companies in New York - 4

Founded in 1991 as Lucid Technologies, Inc. and later Lucid, Inc., Caliber I.D. offers in-vivo confocal microscopes designed specifically for imaging skin and other tissue. Caliber I.D.Õs Rapid Cell ID technology enables scientists and physicians to characterize intact normal and abnormal cellular architecture that is otherwise invisible to the naked eye.

Positron Corporation is a medical technology company that co-develops, manufactures, and sells state-of-the-art PET and PET-CT imaging systems and clinical services to nuclear medicine healthcare providers throughout North America. Positron specializes in the field of cardiac Positron Emission Tomography (PET) imaging, the gold standard in cardiac diagnostics. Positron's innovative PET/PET-CT technologies, clinical services and practice solutions enables healthcare providers to accurately diagnose coronary artery disease and improve patient outcomes while practicing cost effective medicine. Positron's Attrius® PET and NeuSight PET-CT imaging systems and distinct market position are substantial advantages unique to Positron will facilitate the adoption of cardiac PET and the growth of the nuclear imaging market. Positron will soon offer a state-of-the-art PET-CT 4D molecular imaging device in the Affinity PET-CT 4D 64-Slice. Positron's PET-CT(s) will enable nuclear cardiologists to utilize the full capabilities of molecular imaging and nuclear medicine. Positron's PET-CT systems will enable the Company to fully service and meet the demands of the vast oncology imaging segment of nuclear medicine. Positron is committed to expanding the cardiac and oncology PET modality by delivering the best technology and value to imaging specialists and will continue to advance its technology through its co-developer, supplier, and R&D venture with Shenyang Intelligent Neuclear Technology Co a subsidiary of Neusoft Medical Systems. Positron was founded in 1983 and is based in Niagara Falls, NY.

Summit Biomedical Imaging, LLC., a spin-off company from Memorial Sloan Kettering Cancer Center (MSK, New York City), was founded by Thomas Reiner and Christian Brand in 2016. Recently, Summit Biomedical Imaging was awarded a federal grant through NIH's Small Business Innovation Research (SBIR) program, also known as America's Seed Fund, to support the strong potential of commercialization of their innovative biomedical technology. This early-stage funding from the National Cancer Institute (NCI) allowed them to open their Research and Development facilities in the heart of New York City to develop novel targeted cancer diagnostics.

Terran Biosciences is a biotech platform company devoted to the development of therapeutics and technologies for patients with neurological and psychiatric diseases. Their portfolio includes a late-stage therapy for schizophrenia, late-stage selective serotonin 2A receptor antagonists, a drug design engine that has enabled first-in-class and best-in-class psychedelic therapies, and an AI-enabled imaging software platform.